BALTIMORE, Md.--DNA Bactofection, a novel technology for introducing genes into cells using live, attenuated invasive bacterial vectors, has been licensed to Microscience Ltd. by the University System ...

A British company developing a vaccine for "Delhi belly" hopes to raise £40m next month when it becomes the latest British biotechnology firm to brave flotation. Microscience, with several drugs in ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Microscience, the biotechnology company developing a vaccine against the most common cause of traveller's diarrhoea or "Delhi belly", is planning to float on Aim for about £100m. The company has ...

LONDON - Microscience Ltd. is forming a 50-50 joint venture company with the Hamburg, Germany, drug discovery services company Evotec OAI to develop small-molecule antimicrobial drugs based on targets ...

LONDON - Microscience Ltd. is being acquired by U.S. company Emergent BioSolutions Inc. in an all-paper deal that values the vaccine specialist at £40 million (US$73.1 million), roughly £5 million ...

FLOTATION of a Wokingham-based biotechnology company will net £10m for its management and founders, including five London doctors. Microscience intends to float on Aim next month, raising £40m of new ...

Microscience, the vaccines developer, pulled its £140m stock market flotation yesterday, blaming poor market demand for its shares. It announced plans to float on the Alternative Investment Market in ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. © 2026 American City Business Journals. All rights ...

Microscience, London, raised $36.4 million in third-round funding. The investment was led by Advent Venture Partners, J.P. Morgan Partners, Apax Partners Funds, and Merlin Biosciences. The company ...